We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Fiverr (FVRR) to Report Q1 Earnings: What's in the Cards?
Read MoreHide Full Article
Fiverr International Ltd. (FVRR - Free Report) is set to report first-quarter 2021 results on May 6.
For the first quarter, the company expects revenues of $63-$65 million, indicating 84-90% growth from the year-ago reported figure. The Zacks Consensus Estimate for the same stands at $64.62 million, suggesting growth of 89.2% from the prior-year quarter.
Further, the Zacks Consensus Estimate for first-quarter bottom line is pegged at a loss of 7 cents per share, whereas it reported a loss of 8 cents in the year-ago quarter.
The company beat estimates in each of the trailing four quarters, the average earnings surprise being 106.82%.
Fiverr’s deepening focus on international expansion is expected to have benefited its first-quarter 2021 performance. Moreover, growing momentum across its global marketplace,with the expansion to French and Spanish languages, is anticipated to have contributed well.
Additionally, expansion into international markets, namely Brazil and Mexico, with payment options in the form of Boleto and Reis, is expected tohave benefited the company in the quarter under review.
Moreover, Fiverr’s platform, which connects people offering logo, poster and brochure designing, photoshop editing, content marketing, web analytics, translation and other services with people outsourcing such work to freelancers, is expected to have benefited from the increasing work-from-home trend, owing to the pandemic in the first quarter.
Further, the company’s increasing traction in performance marketing is likely to have aided it in acquiring buyers in the to-be-reported quarter.
Additionally, the impacts of its strong focus on product and technology enhancements are anticipated to get reflected in the to-be-reported results.
Also, the company’s marketing efficiency, owing to positive trends in both organic and paid channels, is expected to have contributed to its performance in the quarter to be reported.
Additionally, the launch of four industry stores namely Gaming, E-commerce, Architecture and Politics is likely to have benefited the company in expanding catalog and gaining momentum across larger businesses in the quarter under review.
Furthermore, Fiverr’s accelerated Artificial Intelligence efforts through personalization and customer support are anticipated to have driven the first-quarter performance.
What Our Model Says
Our proven model does not conclusively predict an earnings beat for Fiverrthis time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Fiverr has an Earnings ESP of 0.00% and a Zacks Rank #3.
Stocks to Consider
Here are some stocks worth considering as our model shows that these have the right combination of elements to beat estimates this earnings season.
CDW Corporation (CDW - Free Report) has an Earnings ESP of +0.51% and a Zacks Rank of 2 currently.
Synaptics Incorporated (SYNA - Free Report) has an Earnings ESP of +1.60% and a Zacks Rank of 2 at present.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Fiverr (FVRR) to Report Q1 Earnings: What's in the Cards?
Fiverr International Ltd. (FVRR - Free Report) is set to report first-quarter 2021 results on May 6.
For the first quarter, the company expects revenues of $63-$65 million, indicating 84-90% growth from the year-ago reported figure. The Zacks Consensus Estimate for the same stands at $64.62 million, suggesting growth of 89.2% from the prior-year quarter.
Further, the Zacks Consensus Estimate for first-quarter bottom line is pegged at a loss of 7 cents per share, whereas it reported a loss of 8 cents in the year-ago quarter.
The company beat estimates in each of the trailing four quarters, the average earnings surprise being 106.82%.
Fiverr International Lt. Price and EPS Surprise
Fiverr International Lt. price-eps-surprise | Fiverr International Lt. Quote
Factors at Play
Fiverr’s deepening focus on international expansion is expected to have benefited its first-quarter 2021 performance. Moreover, growing momentum across its global marketplace,with the expansion to French and Spanish languages, is anticipated to have contributed well.
Additionally, expansion into international markets, namely Brazil and Mexico, with payment options in the form of Boleto and Reis, is expected tohave benefited the company in the quarter under review.
Moreover, Fiverr’s platform, which connects people offering logo, poster and brochure designing, photoshop editing, content marketing, web analytics, translation and other services with people outsourcing such work to freelancers, is expected to have benefited from the increasing work-from-home trend, owing to the pandemic in the first quarter.
Further, the company’s increasing traction in performance marketing is likely to have aided it in acquiring buyers in the to-be-reported quarter.
Additionally, the impacts of its strong focus on product and technology enhancements are anticipated to get reflected in the to-be-reported results.
Also, the company’s marketing efficiency, owing to positive trends in both organic and paid channels, is expected to have contributed to its performance in the quarter to be reported.
Additionally, the launch of four industry stores namely Gaming, E-commerce, Architecture and Politics is likely to have benefited the company in expanding catalog and gaining momentum across larger businesses in the quarter under review.
Furthermore, Fiverr’s accelerated Artificial Intelligence efforts through personalization and customer support are anticipated to have driven the first-quarter performance.
What Our Model Says
Our proven model does not conclusively predict an earnings beat for Fiverrthis time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Fiverr has an Earnings ESP of 0.00% and a Zacks Rank #3.
Stocks to Consider
Here are some stocks worth considering as our model shows that these have the right combination of elements to beat estimates this earnings season.
Vishay Intertechnology, Inc. (VSH - Free Report) has an Earnings ESP of +5.22% and a Zacks Rank #2, at present. You can see the complete list of today’s Zacks #1 Rankstocks here.
CDW Corporation (CDW - Free Report) has an Earnings ESP of +0.51% and a Zacks Rank of 2 currently.
Synaptics Incorporated (SYNA - Free Report) has an Earnings ESP of +1.60% and a Zacks Rank of 2 at present.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>